An RNA-sequencing analysis of a sorafenib-resistant model identified EPHB2 as the most significantly upregulated kinase, and further showed that EPHB2 expression increased stepwise from normal liver tissue to fibrotic liver tissue to HCC tissue and was correlated with poor prognosis. This evidence concerns the gene EPHB2 and hepatocellular carcinoma.